HEADER TRANSFERASE/INHIBITOR 20-JUN-12 4FNY TITLE CRYSTAL STRUCTURE OF THE R1275Q ANAPLASTIC LYMPHOMA KINASE CATALYTIC TITLE 2 DOMAIN IN COMPLEX WITH A BENZOXAZOLE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALK TYROSINE KINASE RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 1084-1410; COMPND 5 SYNONYM: ANAPLASTIC LYMPHOMA KINASE; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ALK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS RECEPTOR TYROSINE KINASE, INHIBITOR, CRIZOTINIB, NEUROBLASTOMA, KEYWDS 2 CD246, PHOSPHOTRANSFERASE, NPM-ALK, EML4-ALK, TRANSFERASE-INHIBITOR KEYWDS 3 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.A.WHITTINGTON,L.F.EPSTEIN,H.CHEN REVDAT 3 28-FEB-24 4FNY 1 REMARK SEQADV REVDAT 2 14-NOV-12 4FNY 1 JRNL REVDAT 1 29-AUG-12 4FNY 0 JRNL AUTH L.F.EPSTEIN,H.CHEN,R.EMKEY,D.A.WHITTINGTON JRNL TITL THE R1275Q NEUROBLASTOMA MUTANT AND CERTAIN ATP-COMPETITIVE JRNL TITL 2 INHIBITORS STABILIZE ALTERNATIVE ACTIVATION LOOP JRNL TITL 3 CONFORMATIONS OF ANAPLASTIC LYMPHOMA KINASE. JRNL REF J.BIOL.CHEM. V. 287 37447 2012 JRNL REFN ISSN 0021-9258 JRNL PMID 22932897 JRNL DOI 10.1074/JBC.M112.391425 REMARK 2 REMARK 2 RESOLUTION. 2.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 11662 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.196 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.400 REMARK 3 FREE R VALUE TEST SET COUNT : 866 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.45 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.51 REMARK 3 REFLECTION IN BIN (WORKING SET) : 680 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.80 REMARK 3 BIN R VALUE (WORKING SET) : 0.2370 REMARK 3 BIN FREE R VALUE SET COUNT : 63 REMARK 3 BIN FREE R VALUE : 0.2850 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2154 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 67 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 38.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.56 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.49000 REMARK 3 B22 (A**2) : -1.70000 REMARK 3 B33 (A**2) : 1.21000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.540 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.290 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.181 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.793 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.938 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.896 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2240 ; 0.008 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 1546 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3037 ; 1.254 ; 1.998 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3756 ; 0.838 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 268 ; 5.405 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 97 ;36.463 ;23.918 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 378 ;15.016 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 15 ;16.813 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 331 ; 0.064 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2435 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 432 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4FNY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-JUN-12. REMARK 100 THE DEPOSITION ID IS D_1000073136. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-JUL-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11721 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.450 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.10100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.38400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 3350, 0.2 M DI-AMMONIUM REMARK 280 CITRATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.22700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.03000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.24600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.03000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.22700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.24600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 1084 REMARK 465 THR A 1085 REMARK 465 SER A 1086 REMARK 465 THR A 1087 REMARK 465 ILE A 1088 REMARK 465 MET A 1089 REMARK 465 THR A 1090 REMARK 465 ASP A 1091 REMARK 465 TYR A 1092 REMARK 465 ASN A 1093 REMARK 465 PRO A 1094 REMARK 465 ASN A 1095 REMARK 465 TYR A 1096 REMARK 465 SER A 1097 REMARK 465 PHE A 1098 REMARK 465 ALA A 1099 REMARK 465 GLY A 1100 REMARK 465 LYS A 1101 REMARK 465 THR A 1102 REMARK 465 GLY A 1125 REMARK 465 ALA A 1126 REMARK 465 PHE A 1127 REMARK 465 MET A 1138 REMARK 465 PRO A 1139 REMARK 465 ASN A 1140 REMARK 465 ASP A 1141 REMARK 465 PRO A 1142 REMARK 465 SER A 1143 REMARK 465 SER A 1216 REMARK 465 GLN A 1217 REMARK 465 PRO A 1218 REMARK 465 SER A 1219 REMARK 465 GLY A 1272 REMARK 465 MET A 1273 REMARK 465 ALA A 1274 REMARK 465 GLN A 1275 REMARK 465 ASP A 1276 REMARK 465 ILE A 1277 REMARK 465 TYR A 1278 REMARK 465 ARG A 1279 REMARK 465 ALA A 1280 REMARK 465 SER A 1281 REMARK 465 TYR A 1282 REMARK 465 TYR A 1283 REMARK 465 ARG A 1284 REMARK 465 LYS A 1285 REMARK 465 GLY A 1286 REMARK 465 GLY A 1287 REMARK 465 VAL A 1405 REMARK 465 GLU A 1406 REMARK 465 GLU A 1407 REMARK 465 GLU A 1408 REMARK 465 GLU A 1409 REMARK 465 LYS A 1410 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A1106 -36.85 -39.90 REMARK 500 ASP A1249 46.05 -156.28 REMARK 500 PRO A1331 -55.61 -28.40 REMARK 500 PRO A1403 3.96 -67.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE I3K A 1501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4FNW RELATED DB: PDB REMARK 900 RELATED ID: 4FNX RELATED DB: PDB REMARK 900 RELATED ID: 4FNZ RELATED DB: PDB REMARK 900 RELATED ID: 4FOB RELATED DB: PDB REMARK 900 RELATED ID: 4FOC RELATED DB: PDB REMARK 900 RELATED ID: 4FOD RELATED DB: PDB DBREF 4FNY A 1084 1410 UNP Q9UM73 ALK_HUMAN 1084 1410 SEQADV 4FNY SER A 1097 UNP Q9UM73 CYS 1097 ENGINEERED MUTATION SEQADV 4FNY GLN A 1275 UNP Q9UM73 ARG 1275 ENGINEERED MUTATION SEQRES 1 A 327 ARG THR SER THR ILE MET THR ASP TYR ASN PRO ASN TYR SEQRES 2 A 327 SER PHE ALA GLY LYS THR SER SER ILE SER ASP LEU LYS SEQRES 3 A 327 GLU VAL PRO ARG LYS ASN ILE THR LEU ILE ARG GLY LEU SEQRES 4 A 327 GLY HIS GLY ALA PHE GLY GLU VAL TYR GLU GLY GLN VAL SEQRES 5 A 327 SER GLY MET PRO ASN ASP PRO SER PRO LEU GLN VAL ALA SEQRES 6 A 327 VAL LYS THR LEU PRO GLU VAL CYS SER GLU GLN ASP GLU SEQRES 7 A 327 LEU ASP PHE LEU MET GLU ALA LEU ILE ILE SER LYS PHE SEQRES 8 A 327 ASN HIS GLN ASN ILE VAL ARG CYS ILE GLY VAL SER LEU SEQRES 9 A 327 GLN SER LEU PRO ARG PHE ILE LEU LEU GLU LEU MET ALA SEQRES 10 A 327 GLY GLY ASP LEU LYS SER PHE LEU ARG GLU THR ARG PRO SEQRES 11 A 327 ARG PRO SER GLN PRO SER SER LEU ALA MET LEU ASP LEU SEQRES 12 A 327 LEU HIS VAL ALA ARG ASP ILE ALA CYS GLY CYS GLN TYR SEQRES 13 A 327 LEU GLU GLU ASN HIS PHE ILE HIS ARG ASP ILE ALA ALA SEQRES 14 A 327 ARG ASN CYS LEU LEU THR CYS PRO GLY PRO GLY ARG VAL SEQRES 15 A 327 ALA LYS ILE GLY ASP PHE GLY MET ALA GLN ASP ILE TYR SEQRES 16 A 327 ARG ALA SER TYR TYR ARG LYS GLY GLY CYS ALA MET LEU SEQRES 17 A 327 PRO VAL LYS TRP MET PRO PRO GLU ALA PHE MET GLU GLY SEQRES 18 A 327 ILE PHE THR SER LYS THR ASP THR TRP SER PHE GLY VAL SEQRES 19 A 327 LEU LEU TRP GLU ILE PHE SER LEU GLY TYR MET PRO TYR SEQRES 20 A 327 PRO SER LYS SER ASN GLN GLU VAL LEU GLU PHE VAL THR SEQRES 21 A 327 SER GLY GLY ARG MET ASP PRO PRO LYS ASN CYS PRO GLY SEQRES 22 A 327 PRO VAL TYR ARG ILE MET THR GLN CYS TRP GLN HIS GLN SEQRES 23 A 327 PRO GLU ASP ARG PRO ASN PHE ALA ILE ILE LEU GLU ARG SEQRES 24 A 327 ILE GLU TYR CYS THR GLN ASP PRO ASP VAL ILE ASN THR SEQRES 25 A 327 ALA LEU PRO ILE GLU TYR GLY PRO LEU VAL GLU GLU GLU SEQRES 26 A 327 GLU LYS HET I3K A1501 32 HETNAM I3K N-(4-CHLOROPHENYL)-5-[(6,7-DIMETHOXYQUINOLIN-4-YL)OXY]- HETNAM 2 I3K 1,3-BENZOXAZOL-2-AMINE FORMUL 2 I3K C24 H18 CL N3 O4 FORMUL 3 HOH *67(H2 O) HELIX 1 1 SER A 1104 LEU A 1108 5 5 HELIX 2 2 PRO A 1112 LYS A 1114 5 3 HELIX 3 3 SER A 1157 PHE A 1174 1 18 HELIX 4 4 LEU A 1204 THR A 1211 1 8 HELIX 5 5 ALA A 1222 ASN A 1243 1 22 HELIX 6 6 ALA A 1251 ARG A 1253 5 3 HELIX 7 7 PRO A 1292 MET A 1296 5 5 HELIX 8 8 PRO A 1297 GLY A 1304 1 8 HELIX 9 9 THR A 1307 SER A 1324 1 18 HELIX 10 10 SER A 1334 SER A 1344 1 11 HELIX 11 11 PRO A 1355 TRP A 1366 1 12 HELIX 12 12 GLN A 1369 ARG A 1373 5 5 HELIX 13 13 ASN A 1375 GLN A 1388 1 14 HELIX 14 14 ASP A 1389 ASN A 1394 1 6 SHEET 1 A 5 ILE A1116 GLY A1123 0 SHEET 2 A 5 VAL A1130 VAL A1135 -1 O VAL A1130 N LEU A1122 SHEET 3 A 5 LEU A1145 THR A1151 -1 O VAL A1149 N TYR A1131 SHEET 4 A 5 PHE A1193 GLU A1197 -1 O LEU A1196 N ALA A1148 SHEET 5 A 5 CYS A1182 SER A1186 -1 N GLY A1184 O LEU A1195 SHEET 1 B 3 GLY A1202 ASP A1203 0 SHEET 2 B 3 CYS A1255 LEU A1257 -1 O LEU A1257 N GLY A1202 SHEET 3 B 3 ALA A1266 ILE A1268 -1 O LYS A1267 N LEU A1256 CISPEP 1 LEU A 1190 PRO A 1191 0 -4.85 SITE 1 AC1 10 ALA A1148 GLU A1167 ILE A1171 LEU A1196 SITE 2 AC1 10 GLU A1197 MET A1199 LEU A1256 ILE A1268 SITE 3 AC1 10 ASP A1270 PHE A1271 CRYST1 52.454 56.492 102.060 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019064 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017702 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009798 0.00000